Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / CL A
-
Total 13F shares
-
28,396,770
-
Share change
-
-1,573,575
-
Total reported value
-
$2,582,227,654
-
Put/Call ratio
-
54%
-
Price per share
-
$90.92
-
Number of holders
-
202
-
Value change
-
-$75,945,501
-
Number of buys
-
107
-
Number of sells
-
89
Institutional Holders of REATA PHARMACEUTICALS INC - CL A (RETA) as of Q1 2023
As of 31 Mar 2023,
REATA PHARMACEUTICALS INC - CL A (RETA) was held by
202 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,396,770 shares.
The largest 10 holders included
CPMG Inc, VANGUARD GROUP INC, BlackRock Inc., PERCEPTIVE ADVISORS LLC, First Light Asset Management, LLC, DEUTSCHE BANK AG\, WELLINGTON MANAGEMENT GROUP LLP, Boxer Capital, LLC, Deep Track Capital, LP, and STATE STREET CORP.
This page lists
202
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.